Crossref
Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer
Journal of Men's Health · 2026 · 22 (5) · 66
DOI: 10.22514/jomh.2026.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Men's Health, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer. Journal of Men's Health, 22(5), 66. https://doi.org/10.22514/jomh.2026.042
Vancouver
Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer. Journal of Men's Health. 2026;22(5):66. doi:10.22514/jomh.2026.042
BibTeX
@article{euvimed2026,
title = {Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer},
journal = {Journal of Men's Health},
year = {2026},
volume = {22},
number = {5},
pages = {66},
doi = {10.22514/jomh.2026.042}
}
EUVIMED